1. Coron CE, Rahmi G, Dray X. ENDOSCOPIC SEMIOLOGY OF THE STOMACH AND THE DUODENUM. :66.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. mars 2015;65(2):87‑108.
3. ald_30_gm_k_estomac_web.pdf [Internet]. [cité 5 juill 2020]. Disponible sur: https://www.has-sante.fr/upload/docs/application/pdf/2011-10/ald_30_gm_k_estomac_web.pdf
4. Chapelle N, Manfredi S, Lepage C, et al. Trends in gastric can‑ cer incidence: a period and birth cohort analysis in a well‑defined French population. Gastric Cancer 2016;19:508–14.
5. Workshop P in the P. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointestinal Endoscopy. 1 déc 2003;58(6):S3‑43.
6. Waddingham W, Graham D, Banks M, Jansen M. The evolving role of endoscopy in the diagnosis of premalignant gastric lesions. F1000Res. 8 juin 2018;7:715.
7. Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open. juin 2014;2(2):E46-50.
8. Chadwick G, Groene O, Riley S, Hardwick R, Crosby T, Hoare J, et al. Gastric Cancers Missed During Endoscopy in England. Clinical Gastroenterology and Hepatology. juill 2015;13(7):1264-1270.e1.
9. Pimenta-Melo AR, Monteiro-Soares M, Libânio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. sept 2016;28(9):1041‑9.
10. Chapelle N, Bouvier A-M, Manfredi S, Drouillard A, Lepage C, Faivre J, et al. Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population. Annals of Surgical Oncology. 23 mai 2016;23.
11. den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, Ter Borg F, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy. 2013;45(4):249‑56.
12. Commissions prévention des cancers digestifs de la SFED et du CREGG, Chollet R, Létard J-C, Vaillant E, Delchier J-C, Canard J-M, et al. Prévention du cancer de l’estomac. Acta Endosc. juin 2014;44(4):219‑22.
13. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. janv 2012;44(1):74‑94.
14. Kaise M. Advanced endoscopic imaging for early gastric cancer. Best Practice & Research Clinical Gastroenterology. août 2015;29(4):575‑87.
15. Kikuste I, Marques-Pereira R, Monteiro-Soares M, Pimentel-Nunes P, Areia M, Leja M, et al. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol. oct 2013;48(10):1108‑17.
16. Kikuste I, Stirna D, Liepniece-Karele I, Leja M, Dinis-Ribeiro M. The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: do we still need histology to select individuals at risk for adenocarcinoma? Eur J Gastroenterol Hepatol. juill 2014;26(7):704‑9.
17. Li C-Q, Li Y, Zuo X-L, Ji R, Li Z, Gu X-M, et al. Magnified and enhanced computed virtual chromoendoscopy in gastric neoplasia: A feasibility study. World J Gastroenterol. 14 juill 2013;19(26):4221‑7.
18. Jung SW, Lim KS, Lim JU, Jeon JW, Shin HP, Kim SH, et al. Flexible spectral imaging color enhancement (FICE) is useful to discriminate among non-neoplastic lesion, adenoma, and cancer of stomach. Dig Dis Sci. oct 2011;56(10):2879‑86.
19. Dohi O, Yagi N, Yoshida S, Ono S, Sanomura Y, Tanaka S, et al. Magnifying Blue Laser Imaging versus Magnifying Narrow-Band Imaging for the Diagnosis of Early Gastric Cancer: A Prospective, Multicenter, Comparative Study. Digestion. 2017;96(3):127‑34.
20. Pimentel-Nunes P, Libanio D, Lage J, Abrantes D, Coimbra M, Esposito G, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 9 juin 2016;48.
21. Ang TL, Pittayanon R, Lau JYW, Rerknimitr R, Ho SH, Singh R, et al. A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions. Eur J Gastroenterol Hepatol. déc 2015;27(12):1473‑8.
22. Ezoe Y, Muto M, Horimatsu T, Minashi K, Yano T, Sano Y, et al. Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study. Gastrointest Endosc. mars 2010;71(3):477‑84.
23. Teh JL, Tan JR, Lau LJF, Saxena N, Salim A, Tay A, et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol. mars 2015;13(3):480-487.e2.
24. Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J.2016;4(5):629-656. doi:10.1177/2050640616664843
25. Soma N. Diagnosis of Helicobacter pylori- related chronic gastritis, gastric adenoma and early gastric cancer by magnifying endoscopy: ME-NBI for diagnosing gastric diseases. Journal of Digestive Diseases. oct 2016;17(10):641‑51.
26. Pimentel-Nunes P, Dinis-Ribeiro M, Soares J, Marcos-Pinto R, Santos C, Rolanda C, et al. A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy. 31 janv 2012;44(03):236‑46.
27. Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. juin 2005;37(6):570‑8.
28. Kono S, Gotoda T, Yoshida S, Oda I, Kondo H, Gatta L, et al. Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol. 14 déc 2015;21(46):13113‑23.
29. Yoshifuku Y, Sanomura Y, Oka S, Kuroki K, Kurihara M, Mizumoto T, et al. Clinical Usefulness of the VS Classification System Using Magnifying Endoscopy with Blue Laser Imaging for Early Gastric Cancer. Gastroenterol Res Pract. 2017;2017:3649705.
30. Redéen S, Petersson F, Jönsson K-A, Borch K. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy. nov 2003;35(11):946‑50.
31. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. janv 2000;95(1):114‑21.
32. Yao K, Doyama H, Gotoda T, Ishikawa H, Nagahama T, Yokoi C, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer. oct 2014;17(4):669‑79.
33. Prise en charge des lésions polypoïdes gastriques par les endoscopistes [Internet]. FMC-HGE. 2012 [cité 5 juill 2020]. Disponible sur: https://www.fmcgastro.org/postu-main/archives/postu-2012-paris/textes-postu-2012-paris/prise-en-charge-des-lesions-polypoides-gastriques-par-les-endoscopistes/